A Swiss microbiota company with two technology platforms: ApyraVax for innovative mucosal vaccines against enteric infections; ApyraMed for live modified biotherapeutics with 2 lead products with indication in cancer immunotherapy of solid tumors and dysbiosis by antibiotics and unhealthy diet.

Location

via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2018
  • Number of employees in Switzerland
    1-9
Key business